Literature DB >> 9663596

Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections.

G Rezza1, E T Lennette, M Giuliani, P Pezzotti, F Caprilli, P Monini, S Buttò, G Lodi, A Di Carlo, J A Levy, B Ensoli.   

Abstract

Three hundred seventy-nine individuals [137 non-injecting drug using (non-IDU) heterosexuals, 130 homosexual men and 112 IDU] attending the human immunodeficiency virus (HIV) testing program of a sexually transmitted disease (STD) clinic in Rome were studied to estimate the prevalence and to identify the modalities of transmission of human herpesvirus-8 (HHV-8) infection. Serological analysis was performed by using an immunofluorescence assay able to detect anti-latent and anti-lytic HHV-8 antibodies. Twelve acquired immunodeficiency syndrome (AIDS)-Kaposi's sarcoma (KS) patients and 94 blood donors were tested as reference population groups. Anti-lytic antibodies were detected in 185 (48.8%) individuals; 52 of them (13.7%) also had anti-latent antibodies. Both anti-lytic and anti-latent antibody prevalence were higher among homosexual men (66.9% and 27.7%, respectively) than among IDU (49.1% and 8.0%, respectively) and non-IDU heterosexuals (31.4% and 5.1%, respectively), and tended to increase with age. Anti-lytic HHV-8 antibodies were associated with syphilis [odds ratio (OR)=3.81] but not with hepatitis C virus (HCV) seropositivity. HIV-infected homosexual men were more likely to have HHV-8 antibodies than those who were HIV-negative. When using anti-latent antibodies the direction of the OR remained the same, although the associations did not often reach statistical significance. Among AIDS-KS patients, 83.3% had anti-lytic and 66.6% had anti-latent antibodies. Among blood donors, 28% had anti-lytic antibodies and 2 of them (2.1%) also had anti-latent antibodies. Our data indicate that HHV-8 seroprevalence increases with age and is higher among homosexual men, particularly those infected with HIV. This is consistent with sexual transmission of HHV-8 infection. In addition, the presence of HHV-8 antibodies in HIV-negative non-IDU heterosexual contacts and in healthy blood donors is consistent with the high incidence of classic KS in Italy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663596     DOI: 10.1002/(sici)1097-0215(19980729)77:3<361::aid-ijc9>3.0.co;2-m

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Human Herpesvirus 8 Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-08       Impact factor: 3.725

2.  Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors.

Authors:  Xing Wang; Bin He; Zhaoxia Zhang; Tao Liu; Hui Wang; Xu Li; Qiong Zhang; Ke Lan; Xiaomei Lu; Hao Wen
Journal:  Virol J       Date:  2010-03-17       Impact factor: 4.099

3.  Herpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort study.

Authors:  Rulin C Hechter; Matthew Budoff; Howard N Hodis; Charles R Rinaldo; Frank J Jenkins; Lisa P Jacobson; Lawrence A Kingsley; Babafemi Taiwo; Wendy S Post; Joseph B Margolick; Roger Detels
Journal:  Atherosclerosis       Date:  2012-03-14       Impact factor: 5.162

Review 4.  Prevalence of Kaposi's sarcoma-associated herpesvirus among intravenous drug users: a systematic review and meta-analysis.

Authors:  Qiwen Fang; Zhenqiu Liu; Zhijie Zhang; Yan Zeng; Tiejun Zhang
Journal:  Virol Sin       Date:  2017-10-13       Impact factor: 4.327

Review 5.  Human herpesvirus 8: biology and role in the pathogenesis of Kaposi's sarcoma and other AIDS-related malignancies.

Authors:  Abel Viejo-Borbolla; Matthias Ottinger; Thomas F Schulz
Journal:  Curr HIV/AIDS Rep       Date:  2004-04       Impact factor: 5.071

Review 6.  Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis.

Authors:  Lyubomir A Dourmishev; Assen L Dourmishev; Diana Palmeri; Robert A Schwartz; David M Lukac
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

Review 7.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

8.  Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies.

Authors:  Abel Viejo-Borbolla; Matthias Ottinger; Thomas F. Schulz
Journal:  Curr Infect Dis Rep       Date:  2003-04       Impact factor: 3.725

Review 9.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

10.  Sexual activity and Kaposi's sarcoma among human immunodeficiency virus type 1 and human herpesvirus type 8-coinfected men.

Authors:  Eric W Nawar; Stephen R Cole; Homayoon Farzadegan; Mallory D Witt; Frank J Jenkins; Joseph B Margolick; John P Phair; Lisa P Jacobson
Journal:  Ann Epidemiol       Date:  2008-05-27       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.